Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites/Experiment 4/Signature 1

From BugSigDB
Needs review

Curated date: 2024/03/22

Curator: Omojokunoluwatomisin

Revision editor(s): Omojokunoluwatomisin

Source: Figure 4C

Description: Gut microbial composition differences between ZC, QD, and ZZD patients.12 significantly different genera were showed by Kruskal wallis H test bar plot.

Abundance in Group 1: increased abundance in moderate pulmonary dysfunction

NCBI Quality ControlLinks
Eubacterium sp.
Lachnospiraceae
Lactococcus
Raoultibacter
Romboutsia
Subdoligranulum

Revision editor(s): Omojokunoluwatomisin